Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 536 participants.
Also called NCT03045562
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 536 participants
- Sponsor
- Green Valley Group of China
- Registry
-
NCT03045562
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03045562. Randomized; quadruple masking; primary purpose treatment. Start 2017-01-20 (actual); primary completion 2018-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI
- Acronym
- SISTEMI
- Condition
- STEMI - ST Elevation Myocardial Infarction
- Intervention (Drug)
- Normal saline
- Intervention (Drug)
- Salvianolate injection
- Lead sponsor
- Green Valley Group of China
Record details
- Record id
cardio:ct-nct03045562- Content hash
e36acff71acd1e09530d561f6d939072f8b3987e21226bea79b4a71f0f70e5c6